人工智能干预的随机对照试验与CONSORT-AI报告准则的一致性
Alexander P L Martindale1, Carrie D Llewellyn2, Richard O de Visser2
1Brighton and Sussex Medical School, Brighton, UK.
Nature communications
|February 22, 2024
概括
人工智能 (AI) 随机对照试验 (RCT) 的报告大多是完整的,但关键的AI特定细节往往缺失. 建议期刊和资助者更多地采用CONSORT-AI指南,以提高人工智能研究的透明度.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的人工智能
- 临床试验报告标准 临床试验报告标准
背景情况:
- 关于人工智能干预的综合报告试验标准扩展 (CONSORT-AI) 在2020年发表,以改善临床试验中AI的报告.
- 自CONSORT-AI出版以来,以人工智能为重点的随机对照试验 (RCT) 报告的完整性和透明度在很大程度上尚未评估.
结论:
- 虽然AI RCT报告量一般很高,但对关键AI特定元素的系统性报告不足仍然存在.
- 期刊和资助机构加强采用CONSORT-AI对于提高人工智能干预报告的完整性和透明度至关重要.
更多相关视频
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
1.3K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
6.9K
相关概念视频
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Randomized Experiments
6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.9K
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
2.2K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.2K
